뇌하수체암 시장 : 암 유형별, 호르몬 유형별, 치료 유형별, 연령층별, 최종 사용자별, 지역별

Pituitary Cancer Market is estimated to be valued at USD 457.7 Mn in 2025 and is expected to reach USD 869.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.

The cause of pituitary cancer is not well understood. But genetics and hormonal imbalances may play a role. Most pituitary tumors are adenomas, or noncancerous. They are not as common as pituitary gland cysts, which are benign (noncancerous).

Symptoms of pituitary cancer often include headaches, vision changes, loss of weight or an inability to gain weight, and trouble with memory and concentration. Some types of pituitary tumors release too many hormones, which can lead to a disease called Cushing's syndrome. In some cases, this disease causes the body to produce too much prolactin, which can cause thinning of the skin in the chest and arms, and weak bones in the legs and feet. Other forms of this condition can cause the breasts to make milk, even when the person is not pregnant. The condition can also cause a wide range of changes in blood pressure, including a flushed face and high blood pressure in the arms or legs.

Market Dynamics:

Rising incidences of pituitary tumors, increasing investments in research and development activities, and technological advancements in treatment methods are expected to drive growth of the global pituitary cancer market during the forecast period. In addition, increased awareness among the populace has led to a higher demand for noninvasive treatments. The market is also driven by a rise in the number of hospitals and clinics that offer specialized services for pituitary tumors.

However, the high cost of cancer treatments is a major factor expected to impede the growth of the global pituitary cancer market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global pituitary cancer market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pituitary cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis International AG, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Endocyte, RECORDATI GROUP, Camurus AB, Endeavor Biomedicines, Inc., and Debiopharm International SA
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pituitary cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pituitary cancer market

Global Pituitary Cancer Market Detailed Segmentation:

• By Cancer Type:
  • Pituitary Adenoma (Benign Tumor)
  • Pituitary Carcinoma (Malignant Tumor)
• By Hormone Type:
  • Prolactinoma
  • Growth Hormone-Secreting Tumor (Acromegaly)
  • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
  • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
  • Gonadotropin-Secreting Tumor
• By Treatment Type:
  • Surgery
  • Radiation Therapy
  • Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
  • Targeted Therapy
  • Chemotherapy
• By Age Group:
  • Pediatric
  • Adult
• By End User:
  • Hospitals
  • Specialty Clinics
  • Cancer Treatment Centers
  • Research Institutes
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profile:
  • Novartis International AG
  • Pfizer Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Endocyte
  • RECORDATI GROUP
  • Camurus AB
  • Endeavor Biomedicines, Inc.
  • Debiopharm International SA

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Pituitary Cancer, By Cancer Type
  • Market Pituitary Cancer, By Hormone Type
  • Market Pituitary Cancer, By Treatment Type
  • Market Pituitary Cancer, By Age Group
  • Market Pituitary Cancer, By End User
  • Market Pituitary Cancer, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing Incidence and Prevalence
• Advancements in Medical Imaging and Diagnostics
• Increased Research and Development
• Growing Demand for Personalized Medicine
  • Restraints
• Limited Awareness and Delayed Diagnosis
• Lack of Standardized Treatment Guidelines
• Limited Treatment Options for Aggressive Pituitary Cancers
• Challenges in Drug Development
  • Opportunities
• Development of Targeted Therapies
• Combination Therapies
• Advancements in Surgical Techniques
• Development of Novel Imaging Modalities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Pituitary Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Pituitary Cancer Market, By Cancer Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Pituitary Adenoma (Benign Tumor)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Pituitary Carcinoma (Malignant Tumor)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Pituitary Cancer Market, By Hormone Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Prolactinoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Growth Hormone-Secreting Tumor (Acromegaly)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Gonadotropin-Secreting Tumor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Pituitary Cancer Market, By Treatment Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Radiation Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Medications(e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Targeted Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Chemotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Pituitary Cancer Market, By Age Group, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

9. Pituitary Cancer Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Cancer Treatment Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

10. Pituitary Cancer Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• GCC
• Israel
• North Africa
• Central Africa
• Rest of Middle East & Africa

11. Competitive Landscape

• Novartis International AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ipsen Biopharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Endocyte
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• RECORDATI GROUP
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Camurus AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Endeavor Biomedicines, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Debiopharm International SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us